This contract is for the supply of two specific pharmaceutical products: Palonosetron and Ondansetron. The contract is a framework agreement, which means it establishes the terms and conditions for future orders of these medications. The buyer is the Central Negotiation for Hospital Purchases in Bel
Contract awarded. Originally published 9 months ago.
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
